Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651079 · ClinicalTrials.gov registry record · Phase 1
GSK1247303 First Time in Human Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00651079: Clinical Trial Phase 1 study, sponsored by GlaxoSmithKline.
NCT00651079 is a Phase 1 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 58 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00651079, a Phase 1 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
To determine safety, tolerability and Pharmacokinetics of GSK1247303
Interventions
- DRUG GSK1247303
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
Why NCT00651079 stopped before completion
NCT00651079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which GSK1247303 is the first listed.
NCT00651079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00651079 about?
NCT00651079 is a clinical study titled "GSK1247303 First Time in Human Study". To determine safety, tolerability and Pharmacokinetics of GSK1247303
What is the current status of trial NCT00651079?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2008-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00651079?
The interventions under investigation include: GSK1247303 (DRUG).
Who is sponsoring clinical trial NCT00651079?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00651079's enrollment target sits among peer trials
58 895th of 2000 higher than 1,100 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia